• Briumvi 150 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  UBLITUXIMAB	150 mg

  ATC: L04A L04AG L04AG14

• Buccolam 10 mg oromucosal solution

  Form: solution, oral

  Active substance	Dosage
  MIDAZOLAM HYDROCHLORide	5,00 mg

  ATC: N05C N05CD N05CD08

• Buccolam 2.5 mg oromucosal solution

  Form: solution, oral

  Active substance	Dosage
  MIDAZOLAM HYDROCHLORide	5,00 mg

  ATC: N05C N05CD N05CD08

• Buccolam 5 mg oromucosal solution

  Form: solution, oral

  Active substance	Dosage
  MIDAZOLAM HYDROCHLORide	5,00 mg

  ATC: N05C N05CD N05CD08

• Buccolam 7.5 mg oromucosal solution

  Form: solution, oral

  Active substance	Dosage
  MIDAZOLAM HYDROCHLORide	5,00 mg

  ATC: N05C N05CD N05CD08

• Modiodal 100 mg tablets

  Form: tablets

  Active substance	Dosage
  MODAFINIL	100 mg

  ATC: N06B N06BA N06BA07

• NiaPelf 100 mg prolonged-release injectable suspension EFG

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	156 mg

  ATC: N05A N05AX N05AX13

• NiaPelf 150 mg prolonged-release injection suspension EFG

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	234 mg

  ATC: N05A N05AX N05AX13

• NiaPelf 25 mg prolonged-release injectable suspension EFG

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	39 mg

  ATC: N05A N05AX N05AX13

• NiaPelf 50 mg prolonged-release injection suspension EFG

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	78 mg

  ATC: N05A N05AX N05AX13

• NiaPelf 75 mg prolonged-release injectable suspension EFG

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	117 mg

  ATC: N05A N05AX N05AX13

• Paxneury 1 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	1,148 mg

  ATC: C02A C02AC C02AC02

• Paxneury 2 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	2,296 mg

  ATC: C02A C02AC C02AC02

• Paxneury 3 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	3,444 mg

  ATC: C02A C02AC C02AC02

• Paxneury 4 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	4,592 mg

  ATC: C02A C02AC C02AC02

• Paxneury 5 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	5,740 mg

  ATC: C02A C02AC C02AC02

• Paxneury 6 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	6,88 mg

  ATC: C02A C02AC C02AC02

• Paxneury 7 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  GUANFACINE HYDROCHLORIDE	8,036 mg

  ATC: C02A C02AC C02AC02